9 3 5215 (Hydrochlorothiazide and Moexipril 25 mg / 15 mg)

Pill imprint 9 3 5215 has been identified as Hydrochlorothiazide and moexipril hydrochloride 25 mg / 15 mg.

Hydrochlorothiazide/moexipril is used in the treatment of high blood pressure and belongs to the drug class antihypertensive combinations. There is positive evidence of human fetal risk during pregnancy. Hydrochlorothiazide/moexipril 25 mg / 15 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for 9 3 5215

Hydrochlorothiazide and moexipril hydrochloride 25 mg / 15 mg 9 3 5215 Front
Hydrochlorothiazide and moexipril hydrochloride 25 mg / 15 mg 9 3 5215 Back
Hydrochlorothiazide and moexipril hydrochloride 25 mg / 15 mg 9 3 5215
Hydrochlorothiazide and moexipril hydrochloride 25 mg / 15 mg 9 3 5215
Hydrochlorothiazide and moexipril hydrochloride
Imprint:
9 3
5215
Strength:
25 mg / 15 mg
Color:
Yellow
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Antihypertensive combinations
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Teva Pharmaceuticals USA
National Drug Code (NDC):
00093-5215
Inactive Ingredients:
lactose monohydrate
magnesium stearate
povidone k29/32
sodium bicarbonate
polyethylene glycol 3350
polyvinyl alcohol
magnesium silicate
titanium dioxide
FD&C Red No. 40
aluminum oxide
FD&C Yellow No. 5
FD&C Yellow No. 6
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
54868-3443 Physicians Total Care Inc (repackager)

Note: Inactive ingredients may vary.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web4)